386 related articles for article (PubMed ID: 17502237)
1. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
Nuttall J; Romano J; Douville K; Galbreath C; Nel A; Heyward W; Mitchnick M; Walker S; Rosenberg Z
Infect Dis Clin North Am; 2007 Mar; 21(1):219-39, x. PubMed ID: 17502237
[TBL] [Abstract][Full Text] [Related]
2. Microbicides and other topical strategies to prevent vaginal transmission of HIV.
Lederman MM; Offord RE; Hartley O
Nat Rev Immunol; 2006 May; 6(5):371-82. PubMed ID: 16639430
[TBL] [Abstract][Full Text] [Related]
3. Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?
Martinez J; Coplan P; Wainberg MA
Antiviral Res; 2006 Sep; 71(2-3):343-50. PubMed ID: 16787667
[TBL] [Abstract][Full Text] [Related]
4. Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
Ketas TJ; Schader SM; Zurita J; Teo E; Polonis V; Lu M; Klasse PJ; Moore JP
Virology; 2007 Aug; 364(2):431-40. PubMed ID: 17428517
[TBL] [Abstract][Full Text] [Related]
5. The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection.
Maeda K; Nakata H; Ogata H; Koh Y; Miyakawa T; Mitsuya H
Curr Opin Pharmacol; 2004 Oct; 4(5):447-52. PubMed ID: 15351348
[TBL] [Abstract][Full Text] [Related]
6. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
[TBL] [Abstract][Full Text] [Related]
7. Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention.
Gaym A
Ethiop Med J; 2006 Oct; 44(4):405-15. PubMed ID: 17370443
[TBL] [Abstract][Full Text] [Related]
8. Cenicriviroc, an orally active CCR5 antagonist for the potential treatment of HIV infection.
Klibanov OM; Williams SH; Iler CA
Curr Opin Investig Drugs; 2010 Aug; 11(8):940-50. PubMed ID: 20721836
[TBL] [Abstract][Full Text] [Related]
9. Prospects of HIV-1 entry inhibitors as novel therapeutics.
Pierson TC; Doms RW; Pöhlmann S
Rev Med Virol; 2004; 14(4):255-70. PubMed ID: 15248253
[TBL] [Abstract][Full Text] [Related]
10. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
[TBL] [Abstract][Full Text] [Related]
11. What's New in HIV/AIDS? Chemokine receptor antagonists: a new era of HIV therapy?
Jülg B; Goebel FD
Infection; 2005 Oct; 33(5-6):408-10. PubMed ID: 16258879
[TBL] [Abstract][Full Text] [Related]
12. Microbicides: a new frontier in HIV prevention.
McGowan I
Biologicals; 2006 Dec; 34(4):241-55. PubMed ID: 17097303
[TBL] [Abstract][Full Text] [Related]
13. Targeting chemokine receptors in HIV: a status report.
Kuhmann SE; Hartley O
Annu Rev Pharmacol Toxicol; 2008; 48():425-61. PubMed ID: 17937593
[TBL] [Abstract][Full Text] [Related]
14. Vaginal microbicides.
O'Brien RF
Adolesc Med Clin; 2006 Oct; 17(3):673-85; abstract xi. PubMed ID: 17030285
[TBL] [Abstract][Full Text] [Related]
15. Microbicides for multidrug-resistant and multitropic HIV-1.
D'Cruz OJ; Uckun FM
Curr Opin Investig Drugs; 2008 Feb; 9(2):152-69. PubMed ID: 18246518
[TBL] [Abstract][Full Text] [Related]
16. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
17. CCR5 antagonists: a new tool in fighting HIV.
Jülg B; Goebel FD
J HIV Ther; 2005 Dec; 10(4):68-71. PubMed ID: 16519245
[TBL] [Abstract][Full Text] [Related]
18. Rectal microbicides in development.
Willyard C
Nat Med; 2009 Aug; 15(8):829. PubMed ID: 19661974
[No Abstract] [Full Text] [Related]
19. New approaches toward anti-HIV chemotherapy.
De Clercq E
J Med Chem; 2005 Mar; 48(5):1297-313. PubMed ID: 15743172
[No Abstract] [Full Text] [Related]
20. The role of receptors in the HIV-1 entry process.
Jones R; Nelson M
Eur J Med Res; 2007 Oct; 12(9):391-6. PubMed ID: 17933719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
